EVFM

Evofem Biosciences, Inc. Common Stock
EVFM

Overview Fund Activity
Delisted

EVFM was delisted on the 10th of August, 2022.

Back to rankings

81 hedge funds and large institutions have $40.8M invested in Evofem Biosciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 24 reducing their positions, and 38 closing their positions.

Holders
81
Holders Change
-22
Holders Change %
-21.36%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
20
Reduced
24
Closed
38
Calls
$2.59M
Puts
$1.29M
Net Calls
+$1.3M
Net Calls Change
+$1.46M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$4.67M
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$5.13M
3
Millennium Management
3
Millennium Management
New York
$4.15M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.92M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$1.7M

Top Sellers

1
Invesco
1
Invesco
Georgia
$0
2
MS
2
Maven Securities
Jersey
$0
3
CCM
3
CAAS Capital Management
New York
$0
4
GLA
4
Great Lakes Advisors
Illinois
$0
5
BlackRock
5
BlackRock
New York
$3.84M
Name Holding Trade Value Shares
Change 		Shares
Change %
CH
101
Canton Hathaway
Rhode Island
– -$2K -67 Closed
GAM
102
Gemmer Asset Management
California
– -$2K -67 Closed
MWP
103
Meridian Wealth Partners
Pennsylvania
– -$2K -67 Closed
CAC
104
Certified Advisory Corp
Florida
– -$1K -43 Closed
PHK
105
Point72 Hong Kong
Hong Kong
– -$1K -32 Closed
HWM
106
HighMark Wealth Management
Minnesota
– -$1K -31 Closed
1 2 3 4
5